Long-term changes in cardiac remodelling in prevalent kidney graft recipients

被引:2
|
作者
Panisset, Valentin [1 ]
Girerd, Nicolas [2 ,3 ,4 ,5 ]
Bozec, Erwan [2 ,3 ,4 ,5 ]
Lamiral, Zohra [2 ,3 ,4 ,5 ]
d'Herve, Quentin [1 ]
Frimat, Luc [1 ]
Huttin, Olivier [6 ]
Girerd, Sophie [1 ,2 ,3 ,4 ,5 ,7 ,8 ]
机构
[1] Univ Hosp Nancy, Nephrol Dept, Vandoeuvre Les Nancy, France
[2] Univ Lorraine, Ctr Invest Clin 1433, Inserm, Vandoeuvre Les Nancy, France
[3] Inserm, U1116, Vandoeuvre Les Nancy, France
[4] CHRU Nancy, Vandoeuvre Les Nancy, France
[5] F CRIN INI CRCT, Vandoeuvre Les Nancy, France
[6] Univ Hosp Nancy, Cardiol Dept, Vandoeuvre Les Nancy, France
[7] CHRU Nancy, Ctr Invest Clin 1433, INSERM,U1116, Nancy, France
[8] 4 Rue Morvan, F-54500 Vandoeuvre Les Nancy, France
关键词
Kidney transplantation; Kidney graft recipients; Echocardiography; Cardiac remodelling; Heart failure; LEFT-VENTRICULAR HYPERTROPHY; RENAL-TRANSPLANT RECIPIENTS; LEFT ATRIAL DIAMETER; SURVIVAL; ADULTS; MANAGEMENT; EVEROLIMUS; PROGNOSIS; OUTCOMES; DISEASE;
D O I
10.1016/j.ijcard.2024.131852
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Approximately 15% of kidney transplant (KT) recipients develop de novo heart failure after KT. There are scarce data reporting the long-term changes in cardiac structure and function among KT recipients. Despite the improvement in renal function, transplant-related complications as well as immunosuppressive therapy could have an impact on cardiac remodelling during follow-up. We aimed to describe the long-term changes in echocardiographic parameters in prevalent KT recipients and identify the clinical and laboratory factors associated with these changes. Methods: A centralised blinded review of two echocardiographic examinations after KT (on average after 17 and 39 months post-KT respectively) was performed among 80 patients (age 50.4 +/- 16.2, diabetes 13.8% pre-KT), followed by linear regression to identify clinico-biological factors related to echocardiographic changes. Results: Left atrial volume index (LAVI) increased significantly (34.2 +/- 10.8 mL/m(2) vs. 37.6 +/- 15.0 mL/m(2), annualised delta 3.1 +/- 11.4 mL/m(2)/year; p = 0.034) while left ventricular ejection fraction (LVEF) decreased (62.1 +/- 9.0% vs. 59.7 +/- 9.9%, annualised delta -2.7 +/- 13.6%/year; p = 0.04). Male sex (beta = 8.112 +/- 2.747; p < 0.01), pre-KT hypertension (beta = 9.725 +/- 4.156; p < 0.05), graft from expanded criteria donor (beta = 3.791 +/- 3.587; p < 0.05), and induction by anti-thymocyte globulin (beta = 7.920 +/- 2.974; p = 0.01) were associated with an increase in LAVI during follow-up. Higher haemoglobin (>12.9 g/dL) at the time of the first echocardiography (beta = 6.029 +/- 2.967; p < 0.05) and ACEi/ARB therapy (beta = 8.306 +/- 3.161; p < 0.05) were associated with an increase in LVEF during follow-up. Conclusion: This study confirms the existence of long-term cardiac remodelling after KT despite dialysis cessation, characterised by an increase in LAVI and a decrease in LVEF. A better management of anaemia and using ACEi/ARB therapy may prevent such remodelling.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] Immune biomarkers and long-term graft survival: a prospective follow-up of 457 kidney transplant recipients
    Ciszek, Michal
    Mucha, Krzysztof
    Foroncewicz, Bartosz
    Zochowska, Dorota
    Kosieradzki, Maciej
    Grochowiecki, Tadeusz
    Durlik, Magdalena
    Gorski, Andrzej
    Paczek, Leszek
    POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 2017, 127 (03): : 178 - 183
  • [42] Systemic inflammation early after kidney transplantation is associated with long-term graft loss: a cohort study
    Heldal, Torbjorn F.
    Asberg, Anders
    Ueland, Thor
    Reisaeter, Anna V.
    Pischke, Soren E.
    Mollnes, Tom E.
    Aukrust, Pal
    Reinholt, Finn
    Hartmann, Anders
    Heldal, Kristian
    Jenssen, Trond G.
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [43] Long-Term Outcomes of Kidney Transplantation in Children
    Winterberg, Pamela D.
    Garro, Rouba
    PEDIATRIC CLINICS OF NORTH AMERICA, 2019, 66 (01) : 269 - +
  • [44] Conversion From Sirolimus to Everolimus in Long-Term Liver Graft Recipients
    Weiler, Nina
    Bilge, Nigar
    Troetschler, Sven
    Vermehren, Johannes
    Schnitzbauer, Andreas Anton
    Herrmann, Eva
    Sarrazin, Christoph
    Zeuzem, Stefan
    Welker, Martin-Walter
    JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 57 (07) : 837 - 845
  • [45] Circulating Arsenic is Associated with Long-Term Risk of Graft Failure in Kidney Transplant Recipients: A Prospective Cohort Study
    Sotomayor, Camilo G.
    Groothof, Dion
    Vodegel, Joppe J.
    Gacitua, Tomas A.
    Gomes-Neto, Antonio W.
    Oste, Maryse C. J.
    Pol, Robert A.
    Ferreccio, Catterina
    Berger, Stefan P.
    Chong, Guillermo
    Slart, Riemer H. J. A.
    Rodrigo, Ramon
    Navis, Gerjan J.
    Touw, Daan J.
    Bakker, Stephan J. L.
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (02)
  • [46] Long-term Patient and Graft Survival of Kidney Transplant Recipients With Hepatitis C Virus Infection in the United States
    Heo, Nae-Yun
    Mannalithara, Ajitha
    Kim, Donghee
    Udompap, Prowpanga
    Tan, Jane C.
    Kim, W. Ray
    TRANSPLANTATION, 2018, 102 (03) : 454 - 460
  • [47] Long-term survival following kidney transplantation in previous lung transplant recipients-An analysis of the UNOS registry
    Osho, Asishana A.
    Hirji, Sameer A.
    Castleberry, Anthony W.
    Mulvihill, Michael S.
    Ganapathi, Asvin M.
    Speicher, Paul J.
    Yerokun, Babatunde
    Snyder, Laurie D.
    Davis, Robert D.
    Hartwig, Mathew G.
    CLINICAL TRANSPLANTATION, 2017, 31 (05)
  • [48] Long-term prognosis of BK virus-associated nephropathy in kidney transplant recipients
    Park, Woo Yeong
    Kang, Seong Sik
    Jin, Kyubok
    Park, Sung Bae
    Choe, Misun
    Han, Seungyeup
    KIDNEY RESEARCH AND CLINICAL PRACTICE, 2018, 37 (02) : 167 - 173
  • [49] Long-term results of desensitization protocol with and without rituximab in sensitized kidney transplant recipients
    Green, Hefziba
    Nesher, Eviatar
    Aizner, Sigal
    Israeli, Moshe
    Klein, Tirza
    Zakai, Hana
    Rahamimov, Ruth
    Rozen-Zvi, Benaya
    Mor, Eytan
    CLINICAL TRANSPLANTATION, 2019, 33 (06)
  • [50] The Impact of Cholecaciferol Supplementation on Bone Mineral Density in Long-Term Kidney Transplant Recipients
    Battaglia, Yuri
    Bellasi, Antonio
    Esposito, Pasquale
    Bortoluzzi, Alessandra
    Rotondi, Silverio
    Andreucci, Michele
    Fiorini, Fulvio
    Russo, Domenico
    Storari, Alda
    BIOMOLECULES, 2023, 13 (04)